Author
Listed:
- Huijun Dong
(Peking University Health Science Center)
- Zihang Pan
(Peking University Health Science Center)
- Pengtao Jiao
(Chinese Academy of Agricultural Sciences
Chinese Academy of Sciences)
- Fei Ye
(China CDC)
- Qi Peng
(Chinese Academy of Sciences)
- Yanying Yu
(Tsinghua University)
- Xinyuan Lai
(Peking University Health Science Center)
- Huan Li
(Peking University Health Science Center)
- Zhao Guan
(Peking University Health Science Center)
- Juan Deng
(Peking University Health Science Center)
- Tao Shen
(Peking University Health Science Center)
- Wenjie Tan
(China CDC)
- Yi Shi
(Chinese Academy of Sciences)
- Qiang Ding
(Tsinghua University)
- Jianyuan Luo
(Peking University Health Science Center)
- Tong Li
(Peking University Health Science Center)
- Hui Zhuang
(Peking University Health Science Center)
- Kuanhui Xiang
(Peking University Health Science Center)
Abstract
Embryonic stem cells (ESCs) display a distinctive resistance against various viruses, irrespective of any interferon response. Nevertheless, the underlying mechanism of this resistance remains unclear. In this study, we identify vesicle-associated membrane protein 5 (VAMP5) as a potent cell-autonomous defense factor against coronaviruses, including SARS-CoV-2, with high expression levels observed in ESCs and mesoderm. VAMP5 not only exhibits functional conservation in restricting the replication of SARS-CoV-2 and its variants, as well as other highly pathogenic coronaviruses, but also shows efficacy in combating the replication of viruses from other families. Mechanistic investigations reveal that VAMP5 localizes to double membrane vesicles (DMVs) and impedes viral replication by relying on its vesicle-side C-terminal domain to interact with the viral non-structural protein 8 (NSP8), thus inhibiting the synthesis of negative-strand RNA. Our research demonstrates that VAMP5 in ESCs disrupts the protected environment of DMVs, which is essential for viral genome replication, and interacts with RNA replication complexes to defend against viral infection. This provides a novel strategy for developing broad-spectrum antiviral treatments.
Suggested Citation
Huijun Dong & Zihang Pan & Pengtao Jiao & Fei Ye & Qi Peng & Yanying Yu & Xinyuan Lai & Huan Li & Zhao Guan & Juan Deng & Tao Shen & Wenjie Tan & Yi Shi & Qiang Ding & Jianyuan Luo & Tong Li & Hui Zhu, 2025.
"Vesicle-associated membrane protein 5 is an intrinsic defense factor for embryonic stem cells against coronaviruses,"
Nature Communications, Nature, vol. 16(1), pages 1-20, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61655-8
DOI: 10.1038/s41467-025-61655-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61655-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.